Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

The market is mainly driven by the significant applications of Tuberculosis Diagnostic in various end use industries. The expanding demands from the Infants and Adults, are propelling Tuberculosis Diagnostic market. Radiographic Method, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diagnostic Laboratory Methods segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tuberculosis Diagnostic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Tuberculosis Diagnostic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Tuberculosis Diagnostic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tuberculosis Diagnostic sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Tuberculosis Diagnostic covered in this report include Thermo Fisher Scientific, Hologic Corporation, Abbott, Becton Dickinson, Roche, bioMerieux, Sanofi, Cepheid and Hain Lifescience, etc.

The global Tuberculosis Diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Thermo Fisher Scientific

Hologic Corporation

Abbott

Becton Dickinson

Roche

bioMerieux

Sanofi

Cepheid

Hain Lifescience

QIAGEN

Scope of Tuberculosis Diagnostic - Market Report

Report Metric	Details
Report Name	Tuberculosis Diagnostic - Market
Forecasted market size in 2029	US$ 3373.5 million
CAGR	3.5%
Forecasted years	2023 - 2029
Global Tuberculosis Diagnostic market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tuberculosis Diagnostic market, Segment by Type:	Radiographic Method Diagnostic Laboratory Methods Nucleic Acid Testing Phage Assay Detection of Latent Infection Cytokine Detection Assay Detection of Drug Resistance
Global Tuberculosis Diagnostic market, by Application	Infants Adults
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Tuberculosis Diagnostic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Tuberculosis Diagnostic - Market size in 2029?

Ans: The Tuberculosis Diagnostic - Market size in 2029 will be US$ 3373.5 million.

What are the Application segmentation covered in the Tuberculosis Diagnostic - Market report?

Ans: The Applications covered in the Tuberculosis Diagnostic - Market report are Infants, Adults

What are the Type segmentation covered in the Tuberculosis Diagnostic - Market report?

Ans: The Types covered in the Tuberculosis Diagnostic - Market report are Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay, Detection of Latent Infection, Cytokine Detection Assay, Detection of Drug Resistance

1 Market Overview of Tuberculosis Diagnostic

1.1 Tuberculosis Diagnostic Market Overview

1.1.1 Tuberculosis Diagnostic Product Scope

1.1.2 Tuberculosis Diagnostic Market Status and Outlook

1.2 Global Tuberculosis Diagnostic Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Tuberculosis Diagnostic Market Size by Region (2018-2029)

1.4 Global Tuberculosis Diagnostic Historic Market Size by Region (2018-2023)

1.5 Global Tuberculosis Diagnostic Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Tuberculosis Diagnostic Market Size (2018-2029)

1.6.1 North America Tuberculosis Diagnostic Market Size (2018-2029)

1.6.2 Europe Tuberculosis Diagnostic Market Size (2018-2029)

1.6.3 Asia-Pacific Tuberculosis Diagnostic Market Size (2018-2029)

1.6.4 Latin America Tuberculosis Diagnostic Market Size (2018-2029)

1.6.5 Middle East & Africa Tuberculosis Diagnostic Market Size (2018-2029)

2 Tuberculosis Diagnostic Market by Type

2.1 Introduction

2.1.1 Radiographic Method

2.1.2 Diagnostic Laboratory Methods

2.1.3 Nucleic Acid Testing

2.1.4 Phage Assay

2.1.5 Detection of Latent Infection

2.1.6 Cytokine Detection Assay

2.1.7 Detection of Drug Resistance

2.2 Global Tuberculosis Diagnostic Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Tuberculosis Diagnostic Historic Market Size by Type (2018-2023)

2.2.2 Global Tuberculosis Diagnostic Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Tuberculosis Diagnostic Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Tuberculosis Diagnostic Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Tuberculosis Diagnostic Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Tuberculosis Diagnostic Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Tuberculosis Diagnostic Revenue Breakdown by Type (2018-2029)

3 Tuberculosis Diagnostic Market Overview by Application

3.1 Introduction

3.1.1 Infants

3.1.2 Adults

3.2 Global Tuberculosis Diagnostic Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Tuberculosis Diagnostic Historic Market Size by Application (2018-2023)

3.2.2 Global Tuberculosis Diagnostic Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Tuberculosis Diagnostic Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Tuberculosis Diagnostic Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Tuberculosis Diagnostic Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Tuberculosis Diagnostic Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Tuberculosis Diagnostic Revenue Breakdown by Application (2018-2029)

4 Tuberculosis Diagnostic Competition Analysis by Players

4.1 Global Tuberculosis Diagnostic Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2022)

4.3 Date of Key Players Enter into Tuberculosis Diagnostic Market

4.4 Global Top Players Tuberculosis Diagnostic Headquarters and Area Served

4.5 Key Players Tuberculosis Diagnostic Product Solution and Service

4.6 Competitive Status

4.6.1 Tuberculosis Diagnostic Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Thermo Fisher Scientific

5.1.1 Thermo Fisher Scientific Profile

5.1.2 Thermo Fisher Scientific Main Business

5.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Products, Services and Solutions

5.1.4 Thermo Fisher Scientific Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)

5.1.5 Thermo Fisher Scientific Recent Developments

5.2 Hologic Corporation

5.2.1 Hologic Corporation Profile

5.2.2 Hologic Corporation Main Business

5.2.3 Hologic Corporation Tuberculosis Diagnostic Products, Services and Solutions

5.2.4 Hologic Corporation Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)

5.2.5 Hologic Corporation Recent Developments

5.3 Abbott

5.3.1 Abbott Profile

5.3.2 Abbott Main Business

5.3.3 Abbott Tuberculosis Diagnostic Products, Services and Solutions

5.3.4 Abbott Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)

5.3.5 Becton Dickinson Recent Developments

5.4 Becton Dickinson

5.4.1 Becton Dickinson Profile

5.4.2 Becton Dickinson Main Business

5.4.3 Becton Dickinson Tuberculosis Diagnostic Products, Services and Solutions

5.4.4 Becton Dickinson Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)

5.4.5 Becton Dickinson Recent Developments

5.5 Roche

5.5.1 Roche Profile

5.5.2 Roche Main Business

5.5.3 Roche Tuberculosis Diagnostic Products, Services and Solutions

5.5.4 Roche Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)

5.5.5 Roche Recent Developments

5.6 bioMerieux

5.6.1 bioMerieux Profile

5.6.2 bioMerieux Main Business

5.6.3 bioMerieux Tuberculosis Diagnostic Products, Services and Solutions

5.6.4 bioMerieux Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)

5.6.5 bioMerieux Recent Developments

5.7 Sanofi

5.7.1 Sanofi Profile

5.7.2 Sanofi Main Business

5.7.3 Sanofi Tuberculosis Diagnostic Products, Services and Solutions

5.7.4 Sanofi Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)

5.7.5 Sanofi Recent Developments

5.8 Cepheid

5.8.1 Cepheid Profile

5.8.2 Cepheid Main Business

5.8.3 Cepheid Tuberculosis Diagnostic Products, Services and Solutions

5.8.4 Cepheid Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)

5.8.5 Cepheid Recent Developments

5.9 Hain Lifescience

5.9.1 Hain Lifescience Profile

5.9.2 Hain Lifescience Main Business

5.9.3 Hain Lifescience Tuberculosis Diagnostic Products, Services and Solutions

5.9.4 Hain Lifescience Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)

5.9.5 Hain Lifescience Recent Developments

5.10 QIAGEN

5.10.1 QIAGEN Profile

5.10.2 QIAGEN Main Business

5.10.3 QIAGEN Tuberculosis Diagnostic Products, Services and Solutions

5.10.4 QIAGEN Tuberculosis Diagnostic Revenue (US$ Million) & (2018-2023)

5.10.5 QIAGEN Recent Developments

6 North America

6.1 North America Tuberculosis Diagnostic Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Tuberculosis Diagnostic Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Tuberculosis Diagnostic Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Tuberculosis Diagnostic Market Dynamics

11.1 Tuberculosis Diagnostic Industry Trends

11.2 Tuberculosis Diagnostic Market Drivers

11.3 Tuberculosis Diagnostic Market Challenges

11.4 Tuberculosis Diagnostic Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Thermo Fisher Scientific

List of Tables

Table 1. Global Market Tuberculosis Diagnostic Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Tuberculosis Diagnostic Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Tuberculosis Diagnostic Market Size Share by Region (2018-2023)

Table 4. Global Tuberculosis Diagnostic Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Tuberculosis Diagnostic Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Tuberculosis Diagnostic Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Tuberculosis Diagnostic Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Tuberculosis Diagnostic Revenue Market Share by Type (2018-2023)

Table 9. Global Tuberculosis Diagnostic Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Tuberculosis Diagnostic Revenue Market Share by Type (2024-2029)

Table 11. North America Tuberculosis Diagnostic Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Tuberculosis Diagnostic Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Tuberculosis Diagnostic Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Tuberculosis Diagnostic Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Tuberculosis Diagnostic Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Tuberculosis Diagnostic Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Tuberculosis Diagnostic Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Tuberculosis Diagnostic Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Tuberculosis Diagnostic Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Tuberculosis Diagnostic Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Tuberculosis Diagnostic Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Tuberculosis Diagnostic Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Tuberculosis Diagnostic Revenue Market Share by Application (2018-2023)

Table 24. Global Tuberculosis Diagnostic Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Tuberculosis Diagnostic Revenue Market Share by Application (2024-2029)

Table 26. North America Tuberculosis Diagnostic Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Tuberculosis Diagnostic Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Tuberculosis Diagnostic Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Tuberculosis Diagnostic Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Tuberculosis Diagnostic Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Tuberculosis Diagnostic Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Tuberculosis Diagnostic Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Tuberculosis Diagnostic Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Tuberculosis Diagnostic Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Tuberculosis Diagnostic Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Tuberculosis Diagnostic Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Tuberculosis Diagnostic Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2022)

Table 39. Date of Key Players Enter into Tuberculosis Diagnostic Market

Table 40. Global Tuberculosis Diagnostic Key Players Headquarters and Area Served

Table 41. Tuberculosis Diagnostic Product Solution and Service

Table 42. Global Tuberculosis Diagnostic Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Thermo Fisher Scientific Basic Information List

Table 45. Thermo Fisher Scientific Description and Business Overview

Table 46. Thermo Fisher Scientific Tuberculosis Diagnostic Products, Services and Solutions

Table 47. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Thermo Fisher Scientific (2018-2023)

Table 48. Thermo Fisher Scientific Recent Developments

Table 49. Hologic Corporation Basic Information List

Table 50. Hologic Corporation Description and Business Overview

Table 51. Hologic Corporation Tuberculosis Diagnostic Products, Services and Solutions

Table 52. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Hologic Corporation (2018-2023)

Table 53. Hologic Corporation Recent Developments

Table 54. Abbott Basic Information List

Table 55. Abbott Description and Business Overview

Table 56. Abbott Tuberculosis Diagnostic Products, Services and Solutions

Table 57. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Abbott (2018-2023)

Table 58. Abbott Recent Developments

Table 59. Becton Dickinson Basic Information List

Table 60. Becton Dickinson Description and Business Overview

Table 61. Becton Dickinson Tuberculosis Diagnostic Products, Services and Solutions

Table 62. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Becton Dickinson (2018-2023)

Table 63. Becton Dickinson Recent Developments

Table 64. Roche Basic Information List

Table 65. Roche Description and Business Overview

Table 66. Roche Tuberculosis Diagnostic Products, Services and Solutions

Table 67. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Roche (2018-2023)

Table 68. Roche Recent Developments

Table 69. bioMerieux Basic Information List

Table 70. bioMerieux Description and Business Overview

Table 71. bioMerieux Tuberculosis Diagnostic Products, Services and Solutions

Table 72. Revenue (US$ Million) in Tuberculosis Diagnostic Business of bioMerieux (2018-2023)

Table 73. bioMerieux Recent Developments

Table 74. Sanofi Basic Information List

Table 75. Sanofi Description and Business Overview

Table 76. Sanofi Tuberculosis Diagnostic Products, Services and Solutions

Table 77. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Sanofi (2018-2023)

Table 78. Sanofi Recent Developments

Table 79. Cepheid Basic Information List

Table 80. Cepheid Description and Business Overview

Table 81. Cepheid Tuberculosis Diagnostic Products, Services and Solutions

Table 82. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Cepheid (2018-2023)

Table 83. Cepheid Recent Developments

Table 84. Hain Lifescience Basic Information List

Table 85. Hain Lifescience Description and Business Overview

Table 86. Hain Lifescience Tuberculosis Diagnostic Products, Services and Solutions

Table 87. Revenue (US$ Million) in Tuberculosis Diagnostic Business of Hain Lifescience (2018-2023)

Table 88. Hain Lifescience Recent Developments

Table 89. QIAGEN Basic Information List

Table 90. QIAGEN Description and Business Overview

Table 91. QIAGEN Tuberculosis Diagnostic Products, Services and Solutions

Table 92. Revenue (US$ Million) in Tuberculosis Diagnostic Business of QIAGEN (2018-2023)

Table 93. QIAGEN Recent Developments

Table 94. North America Tuberculosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)

Table 95. North America Tuberculosis Diagnostic Market Size by Country (2024-2029) & (US$ Million)

Table 96. Europe Tuberculosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)

Table 97. Europe Tuberculosis Diagnostic Market Size by Country (2024-2029) & (US$ Million)

Table 98. Asia-Pacific Tuberculosis Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 99. Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2018-2023) & (US$ Million)

Table 100. Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2024-2029) & (US$ Million)

Table 101. Asia-Pacific Tuberculosis Diagnostic Market Share by Region (2018-2023)

Table 102. Asia-Pacific Tuberculosis Diagnostic Market Share by Region (2024-2029)

Table 103. Latin America Tuberculosis Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 104. Latin America Tuberculosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)

Table 105. Latin America Tuberculosis Diagnostic Market Size by Country (2024-2029) & (US$ Million)

Table 106. Middle East & Africa Tuberculosis Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 107. Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2018-2023) & (US$ Million)

Table 108. Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2024-2029) & (US$ Million)

Table 109. Tuberculosis Diagnostic Market Trends

Table 110. Tuberculosis Diagnostic Market Drivers

Table 111. Tuberculosis Diagnostic Market Challenges

Table 112. Tuberculosis Diagnostic Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tuberculosis Diagnostic Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Tuberculosis Diagnostic Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Tuberculosis Diagnostic Market Share by Regions: 2022 VS 2029

Figure 4. Global Tuberculosis Diagnostic Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Tuberculosis Diagnostic Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Tuberculosis Diagnostic Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Tuberculosis Diagnostic Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Tuberculosis Diagnostic Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Tuberculosis Diagnostic Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Radiographic Method

Figure 11. Global Radiographic Method Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Diagnostic Laboratory Methods

Figure 13. Global Diagnostic Laboratory Methods Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Nucleic Acid Testing

Figure 15. Global Nucleic Acid Testing Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Phage Assay

Figure 17. Global Phage Assay Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Product Picture of Detection of Latent Infection

Figure 19. Global Detection of Latent Infection Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 20. Product Picture of Cytokine Detection Assay

Figure 21. Global Cytokine Detection Assay Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 22. Product Picture of Detection of Drug Resistance

Figure 23. Global Detection of Drug Resistance Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 24. Global Tuberculosis Diagnostic Market Size Share by Type: 2022 & 2029

Figure 25. North America Tuberculosis Diagnostic Revenue Market Share by Type (2018-2029)

Figure 26. Europe Tuberculosis Diagnostic Revenue Market Share by Type (2018-2029)

Figure 27. Asia-Pacific Tuberculosis Diagnostic Revenue Market Share by Type (2018-2029)

Figure 28. Latin America Tuberculosis Diagnostic Revenue Market Share by Type (2018-2029)

Figure 29. Middle East and Africa Tuberculosis Diagnostic Revenue Market Share by Type (2018-2029)

Figure 30. Infants Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 31. Adults Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 32. Global Tuberculosis Diagnostic Market Size Share by Application: 2022 & 2029

Figure 33. North America Tuberculosis Diagnostic Revenue Market Share by Application (2018-2029)

Figure 34. Europe Tuberculosis Diagnostic Revenue Market Share by Application (2018-2029)

Figure 35. Asia-Pacific Tuberculosis Diagnostic Revenue Market Share by Application (2018-2029)

Figure 36. Latin America Tuberculosis Diagnostic Revenue Market Share by Application (2018-2029)

Figure 37. Middle East and Africa Tuberculosis Diagnostic Revenue Market Share by Application (2018-2029)

Figure 38. Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 39. Global Top 5 and Top 10 Players Tuberculosis Diagnostic Market Share in 2022

Figure 40. North America Tuberculosis Diagnostic Market Share by Country (2018-2029)

Figure 41. U.S. Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 42. Canada Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 43. Germany Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 44. France Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 45. U.K. Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 46. Italy Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 47. Russia Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 48. Nordic Countries Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 49. Asia-Pacific Tuberculosis Diagnostic Market Share by Region (2018-2029)

Figure 50. China Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 51. Japan Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 52. South Korea Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 53. Southeast Asia Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 54. India Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 55. Australia Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 56. Latin America Tuberculosis Diagnostic Market Share by Country (2018-2029)

Figure 57. Mexico Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 58. Brazil Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 59. Middle East & Africa Tuberculosis Diagnostic Market Share by Country (2018-2029)

Figure 60. Turkey Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 61. Saudi Arabia Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 62. UAE Tuberculosis Diagnostic Market Size (2018-2029) & (US$ Million)

Figure 63. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions